Literature DB >> 14967431

Increased IL-6 and TGF-beta1 concentrations in bronchoalveolar lavage fluid associated with thoracic radiotherapy.

Nicole Barthelemy-Brichant1, Lionel Bosquée, Didier Cataldo, Jean-Luc Corhay, Michel Gustin, Laurence Seidel, Albert Thiry, Benoît Ghaye, Michel Nizet, Adelin Albert, Jean-Marie Deneufbourg, Pierre Bartsch, Betty Nusgens.   

Abstract

PURPOSE: To assess, in lung cancer patients, the effects of thoracic radiotherapy (RT) on the concentrations of transforming growth factor-beta(1) (TGF-beta(1)) and interleukin-6 (IL-6) in the bronchoalveolar lavage (BAL) fluid. METHODS AND MATERIALS: Eleven patients with lung cancer requiring RT as part of their treatment were studied. BAL was performed bilaterally before, during, and 1, 3, and 6 months after RT. Before each BAL session, the patient's status was assessed clinically using pulmonary function tests and an adapted late effects on normal tissue-subjective, objective, management, analytic (LENT-SOMA) scale, including subjective and objective alterations. The National Cancer Institute Common Toxicity Criteria were used to grade pneumonitis. The TGF-beta(1) and IL-6 levels in the BAL fluid were determined using the Easia kit.
RESULTS: The TGF-beta(1) and IL-6 concentrations in the BAL fluid recovered from the irradiated areas were significantly increased by thoracic RT. The increase in TGF-beta(1) levels tended to be greater in the group of patients who developed severe pneumonitis. In the BAL fluid from the nonirradiated areas, the TGF-beta(1) and IL-6 concentrations remained unchanged.
CONCLUSION: The observed increase in TGF-beta(1) and IL-6 concentrations in the BAL fluid recovered from the irradiated lung areas demonstrated that these cytokines may contribute to the process leading to a radiation response in human lung tissue.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14967431     DOI: 10.1016/S0360-3016(03)01614-6

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  28 in total

1.  Does transforming growth factor-beta1 predict for radiation-induced pneumonitis in patients treated for lung cancer?

Authors:  Elizabeth S Evans; Zafer Kocak; Su-Min Zhou; Daniel A Kahn; Hong Huang; Donna R Hollis; Kim L Light; Mitchell S Anscher; Lawrence B Marks
Journal:  Cytokine       Date:  2006-09-18       Impact factor: 3.861

2.  Bleomycin-Induced Pulmonary Changes on Restaging Computed Tomography Scans in Two Thirds of Testicular Cancer Patients Show No Correlation With Fibrosis Markers.

Authors:  Martha W den Hollander; Nico-Derk L Westerink; Sjoukje Lubberts; Alfons H H Bongaerts; Rienhart F E Wolf; Renska Altena; Janine Nuver; Sjoukje F Oosting; Elisabeth G E de Vries; Anna M E Walenkamp; Coby Meijer; Jourik A Gietema
Journal:  Oncologist       Date:  2016-06-21

3.  High superoxide dismutase and low glutathione peroxidase activities in red blood cells predict susceptibility of lung cancer patients to radiation pneumonitis.

Authors:  Eun-Mi Park; Nithya Ramnath; Gary Y Yang; Ji-Yeon Ahn; Yoorim Park; Tae-Young Lee; Ho-Sang Shin; Jihnhee Yu; Clement Ip; Young-Mee Park
Journal:  Free Radic Biol Med       Date:  2006-10-20       Impact factor: 7.376

Review 4.  Role of Platelet-Derived Transforming Growth Factor-β1 and Reactive Oxygen Species in Radiation-Induced Organ Fibrosis.

Authors:  Jasimuddin Ahamed; Jeffrey Laurence
Journal:  Antioxid Redox Signal       Date:  2017-07-05       Impact factor: 8.401

5.  Advances in targeting the transforming growth factor β1 signaling pathway in lung cancer radiotherapy.

Authors:  Zhonghua Lu; Yiting Tang; Judong Luo; Shuyu Zhang; Xifa Zhou; Lei Fu
Journal:  Oncol Lett       Date:  2017-09-18       Impact factor: 2.967

6.  Analysis of serum cytokines in patients with severe acute respiratory syndrome.

Authors:  Yuanchun Zhang; Jing Li; Yuliang Zhan; Lianqiu Wu; Xueying Yu; Wenjian Zhang; Liya Ye; Shiqing Xu; Ruihua Sun; Yunting Wang; Jinning Lou
Journal:  Infect Immun       Date:  2004-08       Impact factor: 3.441

7.  Single nucleotide polymorphism at rs1982073:T869C of the TGFbeta 1 gene is associated with the risk of radiation pneumonitis in patients with non-small-cell lung cancer treated with definitive radiotherapy.

Authors:  Xianglin Yuan; Zhongxing Liao; Zhensheng Liu; Li-E Wang; Susan L Tucker; Li Mao; Xin Shelley Wang; Mary Martel; Ritsuko Komaki; James D Cox; Luka Milas; Qingyi Wei
Journal:  J Clin Oncol       Date:  2009-04-20       Impact factor: 44.544

8.  Anti-IL-6 receptor antibody does not ameliorate radiation pneumonia in mice.

Authors:  Toshiyuki Ogata; Hideya Yamazaki; Teruki Teshima; Takahiro Tsuchiya; Norihiro Nishimoto; Nariaki Matsuura
Journal:  Exp Ther Med       Date:  2012-05-18       Impact factor: 2.447

9.  Interleukin-6 receptor superantagonist Sant7 inhibits TGF-beta-induced proliferation of human lung fibroblasts.

Authors:  L Gallelli; D Falcone; G Pelaia; T Renda; R Terracciano; N Malara; A Vatrella; A Sanduzzi; B D'Agostino; F Rossi; C Vancheri; R Maselli; S A Marsico; R Savino
Journal:  Cell Prolif       Date:  2008-04-24       Impact factor: 6.831

10.  The TGF-beta1 dynamics during radiation therapy and its correlation to symptomatic radiation pneumonitis in lung cancer patients.

Authors:  Ji-Yoon Kim; Yeon-Sil Kim; Young-Kyoon Kim; Hyun-Jin Park; Seung-Joon Kim; Jin-Hyoung Kang; Young-Pil Wang; Hong-Seok Jang; Sang-Nam Lee; Sei-Chul Yoon
Journal:  Radiat Oncol       Date:  2009-11-27       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.